X0609 4 2026-08-18 0 0001802768 Royalty Pharma plc RPRX 0001814238 Hite Christopher false C/O ROYALTY PHARMA PLC 110 E. 59TH STREET NEW YORK NY 10022 0 1 0 0 EVP & Chairman, Partnering 1 Class A Ordinary Shares 2026-08-18 4 S 0 100000 59.9725 D 370401 I By SCH Investment Partners LLC Class A Ordinary Shares 2026-08-19 4 G 0 16800 0 D 23200 D All reported sales were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 20, 2026. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.68 to $60.42 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person made a charitable gift of Class A Ordinary Shares to Lehigh University. In addition to the Class A Ordinary Shares disclosed above, family vehicles controlled by the Reporting Person hold limited partnership interests in RPI US Partners 2019, LP exchangeable into 866,410 Class A Ordinary Shares and Class E Ordinary Shares of Royalty Pharma Holdings Ltd ("RPH") exchangeable into 1,238,789 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions. /s/ Sean Weisberg, as Attorney-in-Fact for Christopher Hite 2026-08-19